A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy

Status:
Completed

Trial end date:
2019-07-10

Target enrollment:

Participant gender:

This is a double-blind, placebo-controlled, randomized-withdrawal, multicenter study of the efficacy and safety of JZP-258.

Phase 3

Jazz Pharmaceuticals